04:38 PM EST, 12/31/2024 (MT Newswires) -- Michael Benkowitz, President and COO, on December 30, 2024, sold 10,000 shares in United Therapeutics ( UTHR ) for $3,566,800. Following the Form 4 filing with the SEC, Benkowitz has control over a total of 2,577 shares of the company, with 2,577 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000156218024008661/xslF345X05/primarydocument.xml